000 01147 a2200325 4500
005 20250518000001.0
264 0 _c20190910
008 201909s 0 0 eng d
022 _a1875-9114
024 7 _a10.1002/phar.2180
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClick, Zach R
245 0 0 _aNew Food and Drug Administration-Approved and Emerging Novel Treatment Options for Acute Myeloid Leukemia.
_h[electronic resource]
260 _bPharmacotherapy
_c11 2018
300 _a1143-1154 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Approval
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aSeddon, Amanda N
700 1 _aBae, Young R
700 1 _aFisher, Justin D
700 1 _aOgunniyi, Adebayo
773 0 _tPharmacotherapy
_gvol. 38
_gno. 11
_gp. 1143-1154
856 4 0 _uhttps://doi.org/10.1002/phar.2180
_zAvailable from publisher's website
999 _c28840175
_d28840175